Definium Therapeutics Inc Earnings Dividend

Definium Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Definium Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.

Definium Therapeutics Inc’s net profit fell -45.18% since last year same period to $-50.44Mn in the Q4 2025. On a quarterly growth basis, Definium Therapeutics Inc has generated 25.02% jump in its net profits since last 3-months.

Definium Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, Definium Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.

Definium Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.48 - a 5.75% jump from last quarter’s estimates.

Definium Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.48.

Definium Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Definium Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.